Nitric oxide and ocular blood flow in patients with IDDM.
about
Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eyeRegulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cellsExpression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stressEvaluation of the Zeiss retinal vessel analyser.Ocular haemodynamics and colour contrast sensitivity in patients with type 1 diabetes.Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans.Nitric oxide regulates retinal vascular tone in humans.A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.The pathogenesis of edema in diabetic maculopathy.Review: taurine: a "very essential" amino acid.Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patientsExhaled NO during graded changes in inhaled oxygen in manHypertensive retinopathy revisited: some answers, more questions.Exogenous L-arginine does not affect angiotensin II-induced renal vasoconstriction in man.Downregulation of reduced-folate transporter by glucose in cultured RPE cells and in RPE of diabetic miceExpression, subcellular localization, and regulation of sigma receptor in retinal muller cells.Impaired retinal vasodilator responses in prediabetes and type 2 diabetes.Regulation of reduced-folate transporter-1 in retinal pigment epithelial cells by folate.Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice.The Role of Sigma1R in Mammalian Retina.Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice.Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles.Diabetic Retinopathy and the NMDA Receptor.Nitric oxide synthase in gingival tissues of patients with chronic periodontitis and with and without diabetes.Treatment of vascular retinopathies with Pycnogenol.Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.Changes of central retinal artery blood flow and endothelial function in patients with coronary artery disease.Insulin is a key determinant of elevated retinal arteriolar flicker response in insulin-resistant individuals.
P2860
Q28362100-F95FCF0C-44A1-46CD-9B10-909504100EDDQ28363533-59A5A130-778E-4997-BADB-79E8FAFE15D6Q28580237-A9722258-14F2-4EB6-984B-789D0E8DF4FFQ30657401-791CB19A-3560-44E3-BB15-3D1544ADD530Q30862876-904322C5-A222-4046-A70F-31874D74B7DCQ30925858-63BC3805-1156-44F6-962C-88FA405249C7Q31142175-14F5D2E9-1787-46E2-B46F-4AFA77EFFF84Q33269618-5B30F84D-EC38-4E7C-83B2-C5C538B76699Q33887327-DBE9ED50-398C-4A52-B8A7-959544A0B30DQ34312980-8F0FD0A9-C157-46EB-98F0-9CE1D1B03782Q34960671-6A8D9A3A-FDE9-4810-BB8B-6FF4E4E15DC9Q35563782-21340879-C361-4BDC-B4C1-C6899F02F99CQ35594054-52DDB9F9-B089-438E-9516-B6E82CC1A615Q35803117-9C2FA7D8-BF65-441D-98C0-07F7BD11AE61Q36266331-786B2E22-F9DC-4359-894E-F7B299895018Q37047868-8F076772-88C4-4010-AA48-DFD51ED3238CQ37110310-A5AD5A1B-ED51-407E-A459-9B5322C54274Q37172802-F57CE067-6D0B-4D59-A505-C4F5C7CE7C32Q37172896-ABF41CC5-7006-4789-8A76-35F222F24BFCQ38896659-124DFA90-CAE7-4B33-9EC7-9C0561A23E0CQ41221957-528D41FC-B552-4FC8-A146-D9F7C0C0385CQ42427172-3680A8BC-4B73-4C56-A6FD-82D1C97D04A8Q42618396-AB0AA73F-7246-4D45-9712-FFF98BDABA1DQ43199257-072D16CB-6EB0-4731-9835-89BDFB8D52E2Q43606567-A2FBB903-A163-4F0C-9145-72C4F1DEEF7FQ43917419-0B1D171D-07EE-47AE-B4C1-A46DCE8B444EQ46990941-0B633382-07A1-4CA0-80A8-152CDEF7F55BQ51302547-BBF46CB2-4433-49A7-8878-6E28EABC1D2A
P2860
Nitric oxide and ocular blood flow in patients with IDDM.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Nitric oxide and ocular blood flow in patients with IDDM.
@en
type
label
Nitric oxide and ocular blood flow in patients with IDDM.
@en
prefLabel
Nitric oxide and ocular blood flow in patients with IDDM.
@en
P2093
P356
P1433
P1476
Nitric oxide and ocular blood flow in patients with IDDM.
@en
P2093
Breiteneder H
Eichler HG
Fasching P
Schmetterer L
P304
P356
10.2337/DIAB.46.4.653
P407
P577
1997-04-01T00:00:00Z